Novoron Bioscience Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)
  • Investors
  • 6

Novoron Bioscience General Information

Description

Operator of a biotechnology company intended to develop novel therapeutic approaches to address neurodegenerative disorders. The company is engaged in the discovery of therapies to regenerate nerves of the central nervous system for multiple sclerosis and spinal cord injury, enabling patients suffering from conditions to recover faster from a damaged CNS.

Contact Information

Website
www.novoron.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 7770 Regents Road
  • Suite 113319
  • San Diego, CA 92122
  • United States
+1 (858) 000-0000

Novoron Bioscience Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novoron Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC Upcoming Pre-Clinical Trials
12. Grant 07-Sep-2021 00000 00.000 Completed Startup
11. Seed Round 07-Jul-2021 000 00.000 0000 Completed Pre-Clinical Trials
10. Grant 01-Sep-2019 00000 0000 Completed Pre-Clinical Trials
9. Grant 01-Apr-2019 00.000 0000 Completed Pre-Clinical Trials
8. Grant 01-Apr-2018 00000 0000 Completed Pre-Clinical Trials
7. Early Stage VC 02-Mar-2018 0000 0000 Completed Pre-Clinical Trials
6. Equity Crowdfunding Completed Pre-Clinical Trials
5. Accelerator/Incubator 13-Sep-2016 Completed Pre-Clinical Trials
4. Grant 01-Sep-2015 $674K Completed Pre-Clinical Trials
To view Novoron Bioscience’s complete valuation and funding history, request access »

Novoron Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Novoron Bioscience’s complete cap table history, request access »

Novoron Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology company intended to develop novel therapeutic approaches to address neurodegenerative disord
Drug Discovery
San Diego, CA
9 As of 2022
00.000
00000 00000

00000000

didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000 000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

uis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure do
0000 000000000
Boston., MA
0 As of 0000
00.00
00000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novoron Bioscience Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pipeline Therapeutics Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000000 Venture Capital-Backed Boston., MA 0 00.00 00000 00.00
00000000 000000000 Accelerator/Incubator Backed Cambridge, MA 0000000000
000000 000 Venture Capital-Backed New Haven, CT 0 0000 0000000000 0000
0000000 000000 Formerly Angel backed Vancouver, Canada 00 000.00 000000000 000.00
To view Novoron Bioscience’s complete competitors history, request access »

Novoron Bioscience Patents

Novoron Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3022269-A1 Methods and compositions for promoting opc differentiation and remyelination using receptor associated protein (rap) Pending 21-Mar-2016 0000000000
US-20190083571-A1 Methods and compositions for promoting opc differentiation and remyelination using receptor associated protein (rap) Abandoned 21-Mar-2016 0000000000 0
US-20200397857-A1 Methods and compositions for promoting opc differentiation and remyelination using receptor associated protein (rap) Pending 21-Mar-2016 0000000000
EP-3433356-A1 Methods and compositions for promoting opc differentiation and remyelination using receptor associated protein (rap) Withdrawn 21-Mar-2016 A61K38/177

Novoron Bioscience Executive Team (4)

Name Title Board Seat Contact Info
Travis Stiles Ph.D Co-Founder, President, Chief Executive Officer, CSO & Board Member
Shawn Gahr Co-Founder, Chief Financial Officer, Chief Operating Officer & Board Member
A. Taylor Bright Ph.D Co-Founder & Advisor
You’re viewing 3 of 4 executive team members. Get the full list »

Novoron Bioscience Board Members (10)

Name Representing Role Since
Alban Gaultier Novoron Bioscience Board Member 000 0000
Jae Lee Novoron Bioscience Board Member 000 0000
Michael Goguen Self Board Member 000 0000
Miguel de los Rios Ph.D Self Board Member 000 0000
Revere Kinkel Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Novoron Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novoron Bioscience Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Two Bear Capital Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Backstage Capital Venture Capital Minority 000 0000 000000 0
RESI on MaRS Innovation Other 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »